Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether Placoplatre is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Placoplatre has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Placoplatre. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Placoplatre's earnings available for a low price, and how does
this compare to other companies in the same industry?
Unable to compare the PB ratio to the industry average as no data exists.
Examine Placoplatre's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Placoplatre's regulatory filings and announcements.
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Placoplatre has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Building industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Placoplatre's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Placoplatre's earnings growth to the France market average as no estimate data is available.
Unable to compare Placoplatre's revenue growth to the France market average as no estimate data is available.
Unable to determine if Placoplatre is high growth as no earnings estimate data is available.
Unable to determine if Placoplatre is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Placoplatre has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data. You can see them here.
Show me the analysis anyway
Placoplatre's last earnings update was 3838 days ago.
The past performance of a company can be measured by how much
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Below we compare
Placoplatre's growth in the last year to its industry (Building).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it
has maintained that growth in the year.
Insufficient past earnings data to establish if Placoplatre's year on year earnings growth rate was positive over the past 5 years.
Unable to compare Placoplatre's 1-year growth to the 5-year average as past earnings data has not been reported.
Unable to compare Placoplatre's 1-year growth to the FR Building industry average as past earnings data has not been reported.
Earnings and Revenue History
over the past 5 years is shown below, any years where they have experienced a
loss will show up in red.
Placoplatre's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
In this section we usually analyse Placoplatre's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Placoplatre has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information. You can see them here.
Show me the analysis anyway
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
The net worth of a company is the difference between its assets and liabilities.
Unable to compare short term assets to short term liabilities as Placoplatre has not reported sufficient balance sheet data.
Unable to establish if Placoplatre's long term commitments exceed its cash and other short term assets as Placoplatre has not reported sufficient balance sheet data.
This treemap shows a more detailed breakdown of
Placoplatre's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Unable to establish if Placoplatre has a high level of physical assets or inventory without balance sheet data.
Placoplatre has no debt, it does not need to be covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
All data from Placoplatre Company Filings, last reported 10 years ago.
ENXTPA:MLPLC Past Debt and Equity Data
Date (Data in EUR Millions)
Cash & Short Term Investments
Placoplatre has no debt.
Placoplatre has not taken on any debt in the past 5 years.
Placoplatre has no debt, it does not need to be covered by operating cash flow.
Placoplatre has no debt, therefore coverage of interest payments is not a concern.
Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. Placoplatre's cash and debt levels may be found in its annual reports archived here.
Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Placoplatre's financial data was last updated here.
Does Placoplatre SA (EPA:MLPLC) Go Up With The Market?
MLPLC’s beta indicates it is a stock that investors may find valuable if they want to reduce the overall market risk exposure of their stock portfolio. … An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive. … I test MLPLC’s ratio of fixed assets to total assets in order to determine how high the risk is associated with this type of constraint.
Placoplatre SA manufactures and supplies insulation solutions for professionals and individuals. Its products include plates, partitions, tiles, plaster and technical coating, doublages, coatings, mortars, glues, soil insulation products, insulation from the outside, profiles, and accessories. The company was incorporated in 1972 and is based in Suresnes, France. Placoplatre SA operates as a subsidiary of Compagnie de Saint-Gobain S.A.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.